150 mg PF-04991532

DRUG2 trials

Sponsors

Pfizer

Conditions

Diabetes Mellitus, Type 2Diabetes, Type 2

Phase 2

Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus

CompletedNCT01336738

PfizerDiabetes, Type 2

Start: 2011-06-30End: 2012-03-31Updated: 2013-08-06

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

CompletedNCT01338870

PfizerDiabetes Mellitus, Type 2

Start: 2011-06-30End: 2012-03-31Updated: 2013-04-23